Hypera SA (HYPMY)
5.85
+0.06
(+1.04%)
USD |
OTCM |
May 17, 16:00
Hypera Price: 5.85 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 5.814 | 5.88 | 5.814 | 5.85 | 15915.00 |
| May 16, 2024 | 5.835 | 5.89 | 5.79 | 5.79 | 1.944M |
| May 15, 2024 | 5.92 | 5.92 | 5.857 | 5.894 | 755.00 |
| May 14, 2024 | 5.938 | 5.94 | 5.88 | 5.918 | 3147.00 |
| May 13, 2024 | 5.912 | 5.958 | 5.895 | 5.925 | 5474.00 |
| May 10, 2024 | 5.86 | 5.870 | 5.826 | 5.826 | 3428.00 |
| May 09, 2024 | 5.82 | 5.916 | 5.79 | 5.916 | 7503.00 |
| May 08, 2024 | 5.88 | 5.93 | 5.85 | 5.93 | 2273.00 |
| May 07, 2024 | 5.962 | 5.989 | 5.962 | 5.986 | 9170.00 |
| May 06, 2024 | 5.922 | 5.965 | 5.90 | 5.90 | 2462.00 |
| May 03, 2024 | 5.926 | 5.956 | 5.90 | 5.935 | 15306.00 |
| May 02, 2024 | 5.728 | 5.942 | 5.704 | 5.736 | 8518.00 |
| May 01, 2024 | 5.573 | 5.573 | 5.37 | 5.37 | 995.00 |
| Apr 30, 2024 | 5.638 | 6.03 | 5.638 | 6.03 | 4722.00 |
| Apr 29, 2024 | 5.62 | 5.89 | 5.60 | 5.844 | 11428.00 |
| Apr 26, 2024 | 5.27 | 5.494 | 5.19 | 5.286 | 4298.00 |
| Apr 25, 2024 | 5.516 | 5.588 | 5.40 | 5.55 | 11131.00 |
| Apr 24, 2024 | 5.52 | 5.583 | 5.44 | 5.44 | 4379.00 |
| Apr 23, 2024 | 5.605 | 5.82 | 5.40 | 5.494 | 5131.00 |
| Apr 22, 2024 | 5.512 | 5.80 | 5.512 | 5.725 | 13656.00 |
| Apr 19, 2024 | 5.50 | 5.58 | 5.47 | 5.50 | 5549.00 |
| Apr 18, 2024 | 5.43 | 5.45 | 5.30 | 5.445 | 10578.00 |
| Apr 17, 2024 | 5.68 | 5.69 | 5.48 | 5.50 | 6275.00 |
| Apr 16, 2024 | 5.60 | 5.706 | 5.59 | 5.675 | 7954.00 |
| Apr 15, 2024 | 5.902 | 5.902 | 5.720 | 5.755 | 20116.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.51
Minimum
Mar 24 2020
9.615
Maximum
Jun 30 2023
7.083
Average
7.04
Median
Jun 10 2021
Price Benchmarks
| Raia Drogasil SA | 4.90 |
| CEL-SCI Corp | 1.27 |
| AIM ImmunoTech Inc | 0.403 |
| IGC Pharma Inc | 0.56 |
| NovaBay Pharmaceuticals Inc | 0.1186 |
Price Related Metrics
| PE Ratio | 10.82 |
| PS Ratio | 2.291 |
| PEG Ratio | 2.021 |
| Price to Book Value | 1.586 |
| Price to Free Cash Flow | 10.29 |
| Earnings Yield | 9.24% |
| Market Cap | 3.703B |
| PEGY Ratio | 1.092 |
| Operating PE Ratio | 7.238 |
| Normalized PE Ratio | 10.71 |